Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess the effect of tumor necrosis factor inhibitors (TNFi) on subclinical cardiovascular disease in patients with psoriatic disease.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev):

Title: Arthritis & rheumatology (Hoboken, N.J.)

Publisher: Wiley-Blackwell

ISSN (Electronic): 2326-5205

ISSN (Print): 2326-5191

Publication date (Electronic): Oct 31 2017

Affiliations

[1 ] Women's College Hospital and University of Toronto, Toronto, Ontario, Canada.

[2 ] National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.

[3 ] University of Waterloo, Waterloo, Ontario, Canada.

[4 ] Arthritis and Rheumatism Associates, Rockville, Maryland.

[5 ] University of Toronto and Toronto Western Hospital, Toronto, Ontario, Canada.

Article

DOI: 10.1002/art.40366

PubMed ID: 29088580

SO-VID: b5282a97-8fd0-42ca-939a-7dad67e4c840

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 35

See all cited by